Literature DB >> 15861504

Mesenteric Castleman's disease.

Sung-Hoon Kim1, Byung-Wook Min, Wan-Bae Kim, Sung-Soo Park, Jun-Won Um, Jae-Bok Lee, Young-Jae Mok, Sang-Yong Choi, Hong-Young Moon, Bum-Hwan Koo, Ju-Han Lee, In-Sun Kim.   

Abstract

We report here a rare case of mesenteric Castleman's disease presenting as a mesenteric mass. A 13-year-old female child was admitted to our hospital complaining of intermittent vague abdominal pain. She had hypochromic anemia, thrombocytosis and an elevated erythrocyte sedimentation rate (ESR). Ultrasonography and computed tomography indicated an intra- abdominal mass might represent a lymphoma or gastrointestinal stromal tumor or leiomyoma, but the definitive preoperative diagnosis couldn't be confirmed. The surgical resection of the mass revealed the mesenteric hyaline vascular-type Castleman's disease.

Entities:  

Mesh：

Year:  2005        PMID： 15861504      PMCID： PMC2823027          DOI： 10.3349/ymj.2005.46.2.289

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN： 0513-5796            Impact factor:   2.759


  9 in total

1.  Mesenteric Castleman's disease: case report.

Authors:  G Demirpolat; A Pourbagher; M Hekimgil; N Elmas; O Kitis; M Korkut; A Memis
Journal:  Abdom Imaging       Date:  2000 Sep-Oct

2.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

3.  Castleman's disease: an unusual retroperitoneal mass.

Authors:  D P Bartkowski; R G Ferrigni
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

Review 4.  Castleman's disease and related disorders.

Authors:  G Frizzera
Journal:  Semin Diagn Pathol       Date:  1988-11       Impact factor: 3.464

5.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

6.  Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.

Authors:  G M Chronowski; C S Ha; R B Wilder; F Cabanillas; J Manning; J D Cox
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

7.  Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man.

Authors:  D A Lowenthal; D A Filippa; M E Richardson; M Bertoni; D J Straus
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

8.  Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia.

Authors:  I Bjarnason; P M Cotes; S Knowles; C Reid; R Wilkins; T J Peters
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

Review 9.  Retroperitoneal Castleman's disease.

Authors:  J L Seco; F Velasco; J S Manuel; S R Serrano; L Tomas; A Velasco
Journal:  Surgery       Date:  1992-11       Impact factor: 3.982
  9 in total
  3 in total

Review 1.  Castleman's disease in childhood: report of three cases and review of the literature.

Authors:  Piero Farruggia; Antonino Trizzino; Nunzia Scibetta; Giovanni Cecchetto; Patrizia Guerrieri; Emanuele S G D'Amore; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2011-10-20       Impact factor: 2.638

2.  Complete anemia reversal after surgical excision of mesenteric hyaline-vascular unicentric Castleman disease.

Authors:  Jimmy Bejjani; Bernard Lemieux; Gilles Gariepy; Rami Younan
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

3.  Laparoscopy-assisted resection for Mesenteric Castleman's disease: Report of a case.

Authors:  Mitsuhiko Ohta; Manabu Yamamoto; Tetsuzo Tagawa; Eiji Tsujita; Ayumi Matsuyama; Jin Okazaki; Tohru Utsunomiya; Shinichi Tsutsui; Megumu Fujihara; Teruyoshi Ishida
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.